CRP and acute graft versus host disease: Patients at risk of acute GVHD can be identified based on pretransplant prognostic parameters, e.g., age, donor-recipient mismatch, extensive pretransplant anticancer treatment, but a recent meta-analysis also identified increased pretransplant CRP levels as a risk factor for severe post-transplant immune-mediated complications [76].